Title : mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis.

Pub. Date : 2022 Apr 15

PMID : 35219732






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A detailed description of signaling pathways of mTORC1 and mTORC2 that are inhibited by rapamycin and other mTOR inhibitor analogues is accentuated. Sirolimus CREB regulated transcription coactivator 1 Mus musculus